The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Qin, Z.
Right arrow Articles by Blankenstein, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Qin, Z.
Right arrow Articles by Blankenstein, T.

The Journal of Immunology, Vol 159, Issue 2 770-776, Copyright © 1997 by American Association of Immunologists

ARTICLES

Interleukin-10 prevents dendritic cell accumulation and vaccination with granulocyte-macrophage colony-stimulating factor gene-modified tumor cells

Z Qin, G Noffz, M Mohaupt and T Blankenstein
Max-Delbruck-Centrum fur Molekulare Medizin, Berlin, Germany.

A wide variety of human tumors express IL-10 for reasons poorly understood. We have analyzed the effect of spontaneous IL-10 expression by a mouse tumor (J558L) on its immunoparalyzing effect. Because "cross- priming" of T cells by host Ag-presenting cells for MHC class I- restricted tumor Ags is a major pathway for induction of tumor immunity and that is enhanced by granulocyte-macrophage (GM) CSF, we expressed this cytokine in J558L cells. GM-CSF-secreting cells were not effective when used for immunization against challenge with the parental tumor. Inhibition of IL-10 expression through an IL-10 antisense retrovirus restored the vaccine efficacy of GM-CSF-producing J558L cells, demonstrating a direct role of IL-10 in paralyzing the GM-CSF-induced antitumor immune response. Since the tumor used for challenge produced IL-10, we conclude that IL-10 interfered primarily with the initiation but not the effector phase of the immune response. Immunohistochemical analysis of the vaccine site showed a GM-CSF-induced accumulation of dendritic cells (DC) (MHC class II+ and DEC-205+) in the absence of IL- 10. In the presence of IL-10, DC accumulation was completely inhibited. Together, our results demonstrate an antagonistic effect of IL-10 with respect to GM-CSF-induced DC accumulation and tumor immunity and suggest a new mechanism by which tumors escape immune recognition: namely by preventing APC from obtaining access to tumor Ags.


This article has been cited by other articles:


Home page
 Cancer Res.Home page
Z. Li, J. Jiang, Z. Wang, J. Zhang, M. Xiao, C. Wang, Y. Lu, and Z. Qin
Endogenous Interleukin-4 Promotes Tumor Development by Increasing Tumor Cell Resistance to Apoptosis
Cancer Res., November 1, 2008; 68(21): 8687 - 8694.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
K. L. Wozniak and S. M. Levitz
Cryptococcus neoformans Enters the Endolysosomal Pathway of Dendritic Cells and Is Killed by Lysosomal Components
Infect. Immun., October 1, 2008; 76(10): 4764 - 4771.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
M. Ahmadi, D. C. Emery, and D. J. Morgan
Prevention of Both Direct and Cross-Priming of Antitumor CD8+ T-Cell Responses following Overproduction of Prostaglandin E2 by Tumor Cells In vivo
Cancer Res., September 15, 2008; 68(18): 7520 - 7529.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
D. C. Bartholomeu, C. Ropert, M. B. Melo, P. Parroche, C. F. Junqueira, S. M. R. Teixeira, C. Sirois, P. Kasperkovitz, C. F. Knetter, E. Lien, et al.
Recruitment and Endo-Lysosomal Activation of TLR9 in Dendritic Cells Infected with Trypanosoma cruzi
J. Immunol., July 15, 2008; 181(2): 1333 - 1344.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
E. Carreras, S. Turner, V. Paharkova-Vatchkova, A. Mao, C. Dascher, and S. Kovats
Estradiol Acts Directly on Bone Marrow Myeloid Progenitors to Differentially Regulate GM-CSF or Flt3 Ligand-Mediated Dendritic Cell Differentiation
J. Immunol., January 15, 2008; 180(2): 727 - 738.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
Z. Li, F. Pradera, T. Kammertoens, B. Li, S. Liu, and Z. Qin
Cross-Talk between T Cells and Innate Immune Cells Is Crucial for IFN-{gamma}-Dependent Tumor Rejection
J. Immunol., August 1, 2007; 179(3): 1568 - 1576.
[Abstract] [Full Text] [PDF]

Home page
 Ann OncolHome page
G Parmiani, C Castelli, L Pilla, M Santinami, M. Colombo, and L Rivoltini
Opposite immune functions of GM-CSF administered as vaccine adjuvant in cancer patients
Ann. Onc., February 1, 2007; 18(2): 226 - 232.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
S. Wang, S. Hong, J. Yang, J. Qian, X. Zhang, E. Shpall, L. W. Kwak, and Q. Yi
Optimizing immunotherapy in multiple myeloma: restoring the function of patients' monocyte-derived dendritic cells by inhibiting p38 or activating MEK/ERK MAPK and neutralizing interleukin-6 in progenitor cells
Blood, December 15, 2006; 108(13): 4071 - 4077.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
K. L. Wozniak, J. M. Vyas, and S. M. Levitz
In Vivo Role of Dendritic Cells in a Murine Model of Pulmonary Cryptococcosis
Infect. Immun., July 1, 2006; 74(7): 3817 - 3824.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
J. Vakkila, R. Jaffe, M. Michelow, and M. T. Lotze
Pediatric cancers are infiltrated predominantly by macrophages and contain a paucity of dendritic cells: a major nosologic difference with adult tumors.
Clin. Cancer Res., April 1, 2006; 12(7): 2049 - 2054.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
S. Wang, J. Yang, J. Qian, M. Wezeman, L. W. Kwak, and Q. Yi
Tumor evasion of the immune system: inhibiting p38 MAPK signaling restores the function of dendritic cells in multiple myeloma
Blood, March 15, 2006; 107(6): 2432 - 2439.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
J. S. Lam, M. K. Mansour, C. A. Specht, and S. M. Levitz
A Model Vaccine Exploiting Fungal Mannosylation to Increase Antigen Immunogenicity
J. Immunol., December 1, 2005; 175(11): 7496 - 7503.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
A. Mao, V. Paharkova-Vatchkova, J. Hardy, M. M. Miller, and S. Kovats
Estrogen Selectively Promotes the Differentiation of Dendritic Cells with Characteristics of Langerhans Cells
J. Immunol., October 15, 2005; 175(8): 5146 - 5151.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
G. Nalbandian, V. Paharkova-Vatchkova, A. Mao, S. Nale, and S. Kovats
The Selective Estrogen Receptor Modulators, Tamoxifen and Raloxifene, Impair Dendritic Cell Differentiation and Activation
J. Immunol., August 15, 2005; 175(4): 2666 - 2675.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
R. M. Kelly, J. Chen, L. E. Yauch, and S. M. Levitz
Opsonic Requirements for Dendritic Cell-Mediated Responses to Cryptococcus neoformans
Infect. Immun., January 1, 2005; 73(1): 592 - 598.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
S.-C. Yang, S. Hillinger, K. Riedl, L. Zhang, L. Zhu, M. Huang, K. Atianzar, B. Y. Kuo, B. Gardner, R. K. Batra, et al.
Intratumoral Administration of Dendritic Cells Overexpressing CCL21 Generates Systemic Antitumor Responses and Confers Tumor Immunity
Clin. Cancer Res., April 15, 2004; 10(8): 2891 - 2901.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
V. Paharkova-Vatchkova, R. Maldonado, and S. Kovats
Estrogen Preferentially Promotes the Differentiation of CD11c+ CD11bintermediate Dendritic Cells from Bone Marrow Precursors
J. Immunol., February 1, 2004; 172(3): 1426 - 1436.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
S. Hillinger, S.-C. Yang, L. Zhu, M. Huang, R. Duckett, K. Atianzar, R. K. Batra, R. M. Strieter, S. M. Dubinett, and S. Sharma
EBV-Induced Molecule 1 Ligand Chemokine (ELC/CCL19) Promotes IFN-{gamma}-Dependent Antitumor Responses in a Lung Cancer Model
J. Immunol., December 15, 2003; 171(12): 6457 - 6465.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
A. S. Yang and E. C. Lattime
Tumor-induced Interleukin 10 Suppresses the Ability of Splenic Dendritic Cells to Stimulate CD4 and CD8 T-Cell Responses
Cancer Res., May 1, 2003; 63(9): 2150 - 2157.
[Abstract] [Full Text] [PDF]

Home page
 J. Leukoc. Biol.Home page
I. D. Davis, M. Jefford, P. Parente, and J. Cebon
Rational approaches to human cancer immunotherapy
J. Leukoc. Biol., January 1, 2003; 73(1): 3 - 29.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
R. A. Wilcox, A. I. Chapoval, K. S. Gorski, M. Otsuji, T. Shin, D. B. Flies, K. Tamada, R. S. Mittler, H. Tsuchiya, D. M. Pardoll, et al.
Expression of Functional CD137 Receptor by Dendritic Cells
J. Immunol., May 1, 2002; 168(9): 4262 - 4267.
[Abstract] [Full Text] [PDF]

Home page
 JEMHome page
S. Ibe, Z. Qin, T. Schuler, S. Preiss, and T. Blankenstein
Tumor Rejection by Disturbing Tumor Stroma Cell Interactions
J. Exp. Med., November 26, 2001; 194(11): 1549 - 1560.
[Abstract] [Full Text] [PDF]

Home page
 Int ImmunolHome page
G. M. Halliday and S. Le
Transforming growth factor-{beta} produced by progressor tumors inhibits, while IL-10 produced by regressor tumors enhances, Langerhans cell migration from skin
Int. Immunol., September 1, 2001; 13(9): 1147 - 1154.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
S. Sharma, M. Stolina, L. Zhu, Y. Lin, R. Batra, M. Huang, R. Strieter, and S. M. Dubinett
Secondary Lymphoid Organ Chemokine Reduces Pulmonary Tumor Burden in Spontaneous Murine Bronchoalveolar Cell Carcinoma
Cancer Res., September 1, 2001; 61(17): 6406 - 6412.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
L. Cervenak, L. Morbidelli, D. Donati, S. Donnini, T. Kambayashi, J. L. Wilson, H. Axelson, E. Castanos-Velez, H.-G. Ljunggren, R. D. W. Malefyt, et al.
Abolished angiogenicity and tumorigenicity of Burkitt lymphoma by interleukin-10
Blood, October 1, 2000; 96(7): 2568 - 2573.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
L. X. Zhu, S. Sharma, M. Stolina, B. Gardner, M. D. Roth, D. P. Tashkin, and S. M. Dubinett
{Delta}-9-Tetrahydrocannabinol Inhibits Antitumor Immunity by a CB2 Receptor-Mediated, Cytokine-Dependent Pathway
J. Immunol., July 1, 2000; 165(1): 373 - 380.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
I. Borrello, E. M. Sotomayor, F.-M. Rattis, S. K. Cooke, L. Gu, and H. I. Levitsky
Sustaining the graft-versus-tumor effect through posttransplant immunization with granulocyte-macrophage colony-stimulating factor (GM-CSF)-producing tumor vaccines
Blood, May 15, 2000; 95(10): 3011 - 3019.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
M. Stolina, S. Sharma, Y. Lin, M. Dohadwala, B. Gardner, J. Luo, L. Zhu, M. Kronenberg, P. W. Miller, J. Portanova, et al.
Specific Inhibition of Cyclooxygenase 2 Restores Antitumor Reactivity by Altering the Balance of IL-10 and IL-12 Synthesis
J. Immunol., January 1, 2000; 164(1): 361 - 370.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
S. Sharma, M. Stolina, Y. Lin, B. Gardner, P. W. Miller, M. Kronenberg, and S. M. Dubinett
T Cell-Derived IL-10 Promotes Lung Cancer Growth by Suppressing Both T Cell and APC Function
J. Immunol., November 1, 1999; 163(9): 5020 - 5028.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
C. Curiel-Lewandrowski, K. Mahnke, M. Labeur, B. Roters, W. Schmidt, R. D. Granstein, T. A. Luger, T. Schwarz, and S. Grabbe
Transfection of Immature Murine Bone Marrow-Derived Dendritic Cells with the Granulocyte-Macrophage Colony-Stimulating Factor Gene Potently Enhances Their In Vivo Antigen-Presenting Capacity
J. Immunol., July 1, 1999; 163(1): 174 - 183.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
V. Bronte, D. B. Chappell, E. Apolloni, A. Cabrelle, M. Wang, P. Hwu, and N. P. Restifo
Unopposed Production of Granulocyte-Macrophage Colony-Stimulating Factor by Tumors Inhibits CD8+ T Cell Responses by Dysregulating Antigen-Presenting Cell Maturation
J. Immunol., May 15, 1999; 162(10): 5728 - 5737.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
T. Kanto, N. Hayashi, T. Takehara, T. Tatsumi, N. Kuzushita, A. Ito, Y. Sasaki, A. Kasahara, and M. Hori
Impaired Allostimulatory Capacity of Peripheral Blood Dendritic Cells Recovered from Hepatitis C Virus-Infected Individuals
J. Immunol., May 1, 1999; 162(9): 5584 - 5591.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
R. N. L. Motte, A. H. Sharpe, J. A. Bluestone, and M. B. Mokyr
Host B7-1 and B7-2 Costimulatory Molecules Contribute to the Eradication of B7-1-Transfected P815 Tumor Cells Via a CD8+ T Cell-Dependent Mechanism
J. Immunol., April 15, 1999; 162(8): 4817 - 4823.
[Abstract] [Full Text] [PDF]

Home page
 JEMHome page
T. Schuler, Z. Qin, S. Ibe, N. Noben-Trauth, and T. Blankenstein
T Helper Cell Type 1-associated and Cytotoxic T Lymphocyte-mediated Tumor Immunity Is Impaired in Interleukin 4-deficient Mice
J. Exp. Med., March 1, 1999; 189(5): 803 - 810.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
P. Hubert, F. van den Brule, S. L. Giannini, E. Franzen-Detrooz, J. Boniver, and P. Delvenne
Colonization of in Vitro-Formed Cervical Human Papillomavirus-Associated (Pre)Neoplastic Lesions with Dendritic Cells : Role of Granulocyte/Macrophage Colony-Stimulating Factor
Am. J. Pathol., March 1, 1999; 154(3): 775 - 784.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
B. K. Halak, H. C. Maguire Jr., and E. C. Lattime
Tumor-induced Interleukin-10 Inhibits Type 1 Immune Responses Directed at a Tumor Antigen As Well As a Non-Tumor Antigen Present at the Tumor Site
Cancer Res., February 1, 1999; 59(4): 911 - 917.
[Abstract] [Full Text] [PDF]

Home page
 JEMHome page
P. A. Stumbles, J. A. Thomas, C. L. Pimm, P. T. Lee, T. J. Venaille, S. Proksch, and P. G. Holt
Resting Respiratory Tract Dendritic Cells Preferentially Stimulate T Helper Cell Type 2 (Th2) Responses and Require Obligatory Cytokine Signals for Induction of  Th1 Immunity
J. Exp. Med., December 7, 1998; 188(11): 2019 - 2031.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
S. P. Lee, C. M. Constandinou, W. A. Thomas, D. Croom-Carter, N. W. Blake, P. G. Murray, J. Crocker, and A. B. Rickinson
Antigen Presenting Phenotype of Hodgkin Reed-Sternberg Cells: Analysis of the HLA Class I Processing Pathway and the Effects of Interleukin-10 on Epstein-Barr Virus-Specific Cytotoxic T-Cell Recognition
Blood, August 1, 1998; 92(3): 1020 - 1030.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1997 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1997 by The American Association of Immunologists, Inc. All rights reserved.